Latest filing published 12 Dec 2025 for Aardvark Therapeutics, Inc., €87k. Read the official filing
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Tien-Li Lee on record concern Aardvark Therapeutics, Inc. We count 7 filings; the first trade dates from 14 February 2025 and the latest from 11 December 2025.
Purchases make up the whole of the open-market record (4 purchases, €230k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises.
In size, the median ticket on the buying side is €57k. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +26.9%. These figures describe past trades and do not predict future prices.
The newest entry dates from 12 December 2025: an open-market purchase of €87k, in Aardvark Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations